Skip to search formSkip to main contentSkip to account menu

B-Cell Maturation Antigen

Known as: CD269 Antigen, B-Cell Maturation Antigen [Chemical/Ingredient], CD Antigen CD269 
A member of the tumor necrosis factor receptor superfamily found on mature B-LYMPHOCYTES. It has specificity for B CELL ACTIVATING FACTOR and TUMOR… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Immunotherapy has provided treatment options for cancers that are otherwise refractory to standard approaches. One… 
2017
2017
Background: Multiple myeloma (MM) is a usually fatal malignancy of plasma cells, with no current therapy considered curative… 
Review
2017
Review
2017
Introduction: CAR T cell-based immunotherapy has shown clinical activity in a variety of B-cell malignancies. Specifically, the… 
2017
2017
(57) ABSTRACT The present invention relates to the field of treatment of serious medical syndromes such as severe sepsis and… 
2015
2015
The present invention is the specificity and reactivity of the immune cells, a chimeric antigen receptor is a recombinant… 
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: Lymphomas are still incurable in many… 
2013
2013
FIELD: biotechnology. SUBSTANCE: present invention relates to an isolated nucleic acid molecule encoding a chimeric antigen… 
2008
2008
Crohn's disease (CD) presents as an inflammatory barrier disease with characteristic destructive processes in the intestinal wall…